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  21 
Abstract  22 
Aim The study aimed to compare the frequency and alignment of preoperative anaemia screening and 23 
treatment with Australian guidelines in elective bowel surgery and determine the impact on clinical 24 
outcomes.  25 
Methods We performed a retrospective observational study, with an audit of 559 adult patients who 26 
underwent major elective bowel surgery in an Australian metropolitan hospital, January 2016 to 27 
December 2018. Outcome measures included rate of anaemia, guideline compliance, hospital length 28 
of stay and transfusion rate. 29 
Results Preoperative anaemia assessment occurred in 82.6% of patients. However, only 5.2%received 30 
recommended biochemical tests at least one week before surgery. Only 25.2% of anaemic patients 31 
received preoperative treatment; they experienced a longer hospital length of stay (LOS) (9.93 days vs 32 
7.88 days, p<0.001) and an increased rate of transfusion (OR: 3.186, p<0.05).  33 
Conclusion The gaps between current preoperative anaemia screening, management, and national 34 
guidelines, may place patients at higher risk of poor surgical outcome.   35 
Background: 36 
Preoperative anaemia is common in patients undergoing bowel surgery and is a predictor of poor 37 
surgical outcomes, including increased hospital LOS, morbidity and health expenditure (Michailidou 38 
& Nfonsam 2018, Shander et al 2012). These adverse outcomes may be avoided if anaemia is 39 
addressed in the preoperative setting. This highlights the need for timely anaemia assessment and 40 
prompt treatment in the preoperative setting. 41 
 42 
Patient Blood Management (PBM) is an approach designed to optimise factors associated with blood 43 
loss in the perioperative setting, potentially reducing the incidence of unnecessary transfusion and 44 
improving patient outcomes (Society for the Advancement of Blood Management (SABM) 2019). 45 
The current PBM model consists of three pillars: optimising red blood cell mass, minimising blood 46 
loss, and managing anaemia (SABM 2019). Healthcare facilities that endorse this strategy have 47 
reported significant improvement in surgical outcomes and reduced hospital costs (Leahy et al 2017). 48 
For these reasons, the National Safety and Quality in Health Care Standards (NSQHC) mandate that 49 
hospitals embed PBM in their provision of clinical care; and healthcare providers are encouraged to 50 
form multidisciplinary teams to determine how PBM can be effectively incorporated into local 51 
practices (Australian Commission on Safety and Quality in Health Care 2017, Delaforce et al 2018). 52 
 53 
Since anaemia management is part of PBM, treatment should be commenced on diagnosis, and 54 
consideration given to delaying the surgery, if feasible, to minimise the risk of poor surgical outcomes 55 
(National BloodAuthority (NBA) 2012). Traditionally, oral iron supplementation is indicated if iron 56 
deficiency, with or without anaemia, is confirmed. However, its use is limited by patient complaints 57 
of gastrointestinal side effects and the poor bioavailability of iron salts, especially in those with bowel 58 
conditions (Leal-Noval et al 2013, Madrazo-González et al 2011, Weiss & Goodnough 2005). 59 
Intravenous (IV) iron has been proposed as a superior alternative since it bypasses the gastrointestinal 60 
tract, ensuring a 100% bioavailability and a better side effect profile (Baird-Gunning & Bromley 61 
2016,  Girelli et al 2018). However, the increasing use of iron infusion has led to reports of rare, but 62 
severe hypophosphataemia and permanent skin discolouration, associated with either iron’s 63 
pharmacology or the process of administration (Chen et al 2019, Harris et al 2018).  64 
 65 
To maintain high-quality patient care, healthcare facilities need to examine the level of alignment 66 
between their hospital performance and the national PBM guidelines. Work is currently being 67 
undertaken at our health facility, in order to identify alignment gaps and develop a robust 68 
improvement plan. Other facilities have applied auditing methods to assist in revealing gaps in 69 
practice, including a 2015 Australian study involving hospitals in most states which indicated the 70 
quality of anaemia screening and treatment remains suboptimal (Department of Health and Human 71 
Services Victoria (DHHSV), Blood Matters (BM) 2016). The study revealed only 32% of patients are 72 
receiving timely preoperative anaemia assessment that is needed to differentiate the anaemia type, and 73 
facilitate appropriate management before surgery. Patients should have at least a full blood count 74 
(FBC), ferritin test, and C-Reactive Protein (CRP) at least one week before surgery (DHHSV, BM 75 
2016). Limited Australian data have been published since the 2015 study in the bowel surgery 76 
population (Hong et al 2018). As there is a lack of clinical data on the effect of perioperative anaemia 77 
in bowel surgery patients and uncertainty around the implementation of PBM in the local setting, 78 
close monitoring of current practice is vital to guide PBM implementation and identify areas for 79 
improvement. Our study aimed to investigate the compliance of anaemia assessment and treatment in 80 
accordance with PBM guidelines at a major metropolitan tertiary care hospital, specifically in patients 81 
undergoing bowel surgery, and to find if there was an association between anaemia; length of stay and 82 
risk of transfusion.  83 
 84 
Methods: 85 
We conducted an observational, retrospective chart audit at a large Australian metropolitan teaching 86 
healthcare facility, with ethical review exemption received from the hospital Human Research Ethics 87 
Committee (52917-EXMT/MML/52917 (V1)). This pragmatic approach was chosen as it enabled our 88 
team to address a clinical question, through cost-effective longitudinal data access in a large 89 
population of interest. As health service data were routinely collected without specific a priori 90 
research goals, we conducted and reported this research in accordance with the reporting of studies 91 
Conducted using Observational Routinely-collected health Data (RECORD) guideline (Benchimol et 92 
al 2015). 93 
 94 
Inclusion and exclusion criteria: We included both private and public patients aged 18 or older at 95 
admission who underwent major elective bowel surgery between January 2016 and December 2018. 96 
We used diagnosis-related group (DRG) codes for major bowel surgery: G01A/B/C and G02A/B/C to 97 
assist in patient selection. A team of a surgeon, registered nurse, and pharmacist was formed to assess 98 
whether the surgical procedure met the inclusion criteria and minimise any potential DRG coding 99 
errors. We excluded patients admitted for emergency surgery or those patients without evidence of 100 
preoperative screening. Patients who underwent minor surgery were also excluded as minimal blood 101 
loss is anticipated in their surgery, and thus, are less likely to be affected by preoperative anaemia. 102 
 103 
An electronic audit tool was developed by the research team, using evidence-based criteria, sourced 104 
from both local policy and the PBM Guidelines: Module 2 – Perioperative, published by the NBA 105 
(2012).  Measures were categorised and collected across the patient’s surgical journey (Box 1). 106 
Categories measured were deemed integral to appropriate surgical care and blood management. All 107 
patient data were de-identified to preserve privacy. 108 
 109 
The audit tool was initially piloted for utility, using the electronic medical records of ten patients, to 110 
collect demographics, measures and outcomes described in Box1. Two team members independently 111 
extracted and recorded the data, with any discrepancies or clarifications resolved, and the tool 112 
adjusted prior to data collection.  113 
The primary study outcome was to determine the proportion of patients who were screened as 114 
anaemic, requiring preoperative iron therapy, and did receive it. The questions were developed to 115 
assess the level of compliance with PBM Guidelines (2012); and cases were classified using patient 116 
haemoglobin (Hb) levels as a primary denominator in anaemia screening. Hb levels <130g/L for men 117 
and <120 g/L for women were considered anaemic. Further testing results, including ferritin and CRP 118 
levels, were used to differentiate the type of anaemia. We also compared our laboratory screening 119 
audit results with a 2015 Australian multisite audit which was previously benchmarked against the 120 
NBA PBM guidelines (DHHSV & BM 2016). 121 
 122 
Data and statistical analysis: 123 
Data collected were summarised and reported as means for continuous variables, and as proportions 124 
for categorical variables. Proportion, log-rank, and unpaired t-tests were used as appropriate. Logistic 125 
regression analysis was performed to determine the odds ratio of the testing subjects. Statistical 126 
significance was set as a two-tailed p-value < 0.05. All statistical analysis was performed with R 127 
(version 3.6.1).  128 
 129 
Results: 130 
Within the 3-year period, 863 patient records were retrieved from the hospital electronic medical 131 
record system. After applying the exclusion criteria, 559 patients were included for audit. Patient 132 
characteristics are reported in Table 1. The majority admitted for bowel surgery were cancer patients 133 
(62.6%), followed by inflammatory or infective bowel disease, including Crohn’s disease and 134 
ulcerative colitis (23.1%), bowel disease (10.2%), and ileostomy or colostomy procedure for non-135 
malignant disease (4.1%). 136 
 137 
Of these 559 patients, 462 (82.6%) received some preoperative blood testing for anaemia. Of those 138 
who were assessed, 310 patients (67.1%) were screened less than one week before their surgery. One 139 
hundred and thirty-four (29.0%) patients were assessed 1 week up to 6 weeks and 18 (3.9%) greater 140 
than 6 weeks prior to surgery.  141 
 142 
Of the patients who were screened for preoperative anaemia, FBC results were retrieved for 459 143 
(99.4%). However, other tests that assist in differentiating the type of anaemia were less commonly 144 
conducted alongside the FBC; only 51 (11.0%) patients were assessed for ferritin levels and 92 145 
(19.9%) had their CRP levels tested. In total, 167 (36.1%) patients were found to be anaemic in the 146 
preoperative setting. However, the majority (n=147, 88.0%) were classified to have undifferentiated 147 
anaemia, as further results were needed to determine anaemia type. Table 2 shows the screening tests 148 
performed and other screening results.  When we compared our audit results of screening laboratory 149 
parameters with those from the 2015 multi-state audit (Figure 1), the bar graph indicates our 150 
healthcare facility was performing comparably in relation to the proportion of FBCs undertaken in the 151 
preoperative setting and even better for conduct of renal function tests. However, performance in 152 
determining patient anaemia status for the healthcare facility studied, especially ferritin test results 153 
(11.0% versus 31.2% multi-state audit), was subpar.  154 
 155 
Overall, only 42 (25.2%) patients from the anaemic group received treatment preoperatively, 27 156 
received IV iron, seven took oral iron supplementation and eight had a preoperative transfusion. A 157 
small proportion of the non-anaemic patients also received treatment in the preoperative phase, with 158 
four receiving IV iron (Table 3).  159 
 160 
When comparing the anaemic group with the non-anaemic group, the former had a significantly 161 
higher mean hospital LOS (9.93 days vs 7.88 days, p<0.001, Figure 2). They also had a higher 162 
perioperative transfusion rate than the non-anaemic group (OR: 3.186, p=0.049).  In addition, anaemic 163 
patients required more units of blood than the non-anaemic group (2.43 units vs 1.40 units) (Table 4). 164 
All of these factors are likely to be associated with higher admission-related costs.  165 
  166 
Discussion: 167 
This longitudinal retrospective audit indicated that preoperative anaemia is commonly assessed in 168 
patients undergoing surgery. However, the majority of these assessments did not comply with the 169 
NBA PBM guidelines, with only 5.7% of all patients having the recommended blood tests (at least an 170 
FBC, ferritin test and CRP) within the recommended timeframe (at least 1 week before surgery). As 171 
preoperative anaemia is a powerful predictor of perioperative transfusion, failure to provide quality 172 
anaemia assessment means patients are potentially at risk of preventable suboptimal surgical 173 
outcomes, including an increased mortality rate and in-hospital morbidity, which can be further 174 
translated into an increased health expenditure (Khanna et al 2003, Goel et al 2018). Anaemic patients 175 
should also be screened for anaemia post-surgery, and iron (oral or IV) prescribed if appropriate, with 176 
the use of postoperative transfusion limited to patients who reach the restrictive transfusion threshold 177 
(Muñoz et al 2018).  178 
 179 
Most patients (67.1%) received anaemia assessment less than 1 week before the surgery: these 180 
patients were potentially at a higher risk of poor postoperative outcomes, as the timeframe was 181 
insufficient for anaemia to be investigated and treated without delaying surgery. Suboptimal 182 
laboratory anaemia evaluations, defined as not having all of the preoperative blood tests 183 
recommended by the NBA PBM Guidelines (2012), can also affect diagnosis of anaemia type and 184 
related treatment. This can adversely impact on the appropriate use of iron supplementation, which 185 
should be avoided in patients with anaemia of chronic illness or inflammation without treatment of the 186 
underlying disease (Weiss et al 2019). Treatment may not be effective and may even cause harm in 187 
iron overload disorder or renal impairment (Rostoker 2019). 188 
 189 
The occurrence of preoperative anaemia in our study cohort (36.1%) falls within the reported range of 190 
preoperative anaemia from other bowel or colorectal studies, between 22-76% (Shander et al 2004, 191 
Wilson et al 2017). Our results also confirm that patients undergoing bowel surgery with preoperative 192 
anaemia are subject to poor surgical outcomes, including increased transfusion rates and hospital 193 
LOS, which once again emphasises the importance of adherence to the PBM guidelines. 194 
 195 
Of those who were anaemic and received preoperative treatment, 81% received iron (but only 16.7% 196 
oral iron) and 19.0% a transfusion. Anaemic patients required more units of blood than the non-197 
anaemic group (2.43 units vs 1.40 units).  This mirrors the current evidence base, including a 198 
retrospective study in colorectal cancer surgical patients, where anaemia treated with oral iron 199 
supplementation reduced the need for perioperative transfusion from 27.4% to 9.4% (p < 0.05), 200 
compared to those who did not receive any preoperative treatment (Okuyama et al 2005). In our audit, 201 
four patients without anaemia received preoperative IV iron. This is clinically inappropriate and puts 202 
patients at risk of iatrogenic injury. Unnecessary use of parenteral iron in the non-anaemic population 203 
should be discouraged, and this risk can be minimised by appropriate application of PBM principles.  204 
 205 
The patient group not screened for preoperative anaemia generally had a shorter LOS than those who 206 
were screened (8.62 vs. 5.32, p<0.001). While this may seem counterintuitive, it is probable that 207 
clinicians know which groups of patients tend to be anaemic, and therefore, more likely to order blood 208 
tests in this cohort. However, as the quality of these anaemia assessments was suboptimal, it is 209 
unlikely for the anaemia to be resolved prior to surgery, which might explain the increased hospital 210 
LOS. The comparison of laboratory parameter screening between our hospital and the 2015 multi-211 
state audit suggests potential benefit from improved communication, by surgical leadership teams, to 212 
disseminate the importance of differentiating anaemia types, and how appropriate identification and 213 
management can improve patient outcomes (DHHSV & BM 2016).  214 
 215 
In Australia, PBM implementation remains at an early stage. However, a retrospective multisite audit 216 
of over 600,000 Western Australian elective surgery patients confirmed that a jurisdiction-wide PBM 217 
program can have a positive impact on patient outcomes (reduction of in-hospital mortality odds ratio 218 
0.72), reduced blood product utilisation (41% reduction in units per admission (p < 0.001), and 219 
product-related costs ($18,507,023 AUD saved over six years) (Leahy et al 2017). As timely anaemia 220 
treatment, particularly preoperative iron supplementation, remains a crucial component of PBM, 221 
emphasis should be placed on building a multidisciplinary model to prevent and manage preoperative 222 
anaemia. PBM, along with the application of relevant PBM education, audit and feedback 223 
interventions, combine to play a crucial role in ensuring patient and medication safety. Restrictive 224 
transfusion has also been used by some hospitals, resulting in a dramatic decrease in the proportion of 225 
patients transfused without affecting clinical outcomes (Carson et al 2012).  226 
 227 
The major limitation of our study is that it took place at a single centre, so the results may not reflect 228 
current practice at other healthcare facilities. However, as our patients were drawn from both our 229 
public and private hospitals over a three-year period, it increases the generalisability of our findings. 230 
As bowel surgery is not the only surgery with high bleeding risk and PBM guidelines apply, we 231 
intend to expand our approach to audit a broader range of major surgical procedures. This will allow 232 
surgical specialities to review and compare their local performance, increasing ownership of audit 233 
findings and encouraging development of tailored strategies to overcome identified practice gaps. 234 
Future local audits are essential to maintain quality of practice and guide hospital feedback activities. 235 
At our institution, a newly formed multidisciplinary program of quality improvement will act as a 236 
resource for future activities. Our study failed to demonstrate preoperative iron treatment (oral or IV) 237 
was associated with reduced hospital LOS or units of blood transfused. However, the treated groups 238 
appeared to have a lower rate of transfusion (OR:0.226, p=0.002).    239 
 240 
In conclusion, our PBM bowel surgery audit contributes to contemporary Australian evidence on the 241 
clinical impact of preoperative anaemia screening and treatment. It highlights that patients undergoing 242 
bowel surgery are at moderate risk of being anaemic, risk transfusion and an extended hospital LOS. 243 
Moreover, the current practice around preoperative anaemia screening and subsequent treatment 244 
remains suboptimal. It appears there is still a sizeable gap between the recommended Australian PBM 245 
guidelines and current practice. 246 
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Table 1. Patient demographics  353 





















       
Male:Female (n:n) 258:301 79:88 135:160 44:53 74:109 184:192 
Age (mean) 59.86 63.17 59.3 55.84 57.33 61.09 
       
Principal diagnosis (n,%)       
Bowel disease 57 (10.2%) 11 (6.6%) 30 (10.2%) 16 (16.5%) 23 (12.6%) 34 (9.1%) 
Bowel neoplasm 350 (62.6%) 114 (68.2%) 183 (62.0%) 53 (54.6%) 125 (68.3%) 225 (59.8%) 
Inflammatory/infective 
bowel disease 
129 (23.1%) 37 (22.2%) 72 (24.4%) 20 (20.6%) 32 (17.5%) 97 (25.8%) 
Ileostomy & colostomy 
for non-malignant disease 
23 (4.1%) 5 (3.0%) 10 (3.4%) 8 (8.3%) 3 (1.6%) 20 (5.3%) 
 354 
  355 
Table 2. Screening outcomes  356 
 Total patient (n=559) 
  
Total number of patients screened  462 (82.6%) 
  
Time of assessment prior to surgery  Of those assessed (n=462) 
0-1 day  186 (40.3%) 
2-6 days 124 (26.8%) 
1 week up to 6 weeks 134 (29.0%) 
6 weeks and greater 18 (3.9%) 
  
Blood test performed Of those assessed (n=462) 
FBC 459 (99.4%) 
Ferritin 51 (11.0%) 
Folate 16 (3.5%) 
B12 16 (3.5%) 
CRP 92 (19.9%) 
Renal function 439 (95.0%) 
  
Screening results  Of those assessed (n=462) 
Anaemic 167 (36.1%) 
Non-anaemic 295 (63.9%) 
  
Anaemia classification Of those anaemic (n=167) 
Undifferentiated anaemia 147 (88.0%) 
Iron deficiency anaemia 8 (4.8%) 
Iron deficiency 2 (1.2%) 
Anaemia of inflammation/chronic disease 10 (6.0%) 
  
 357 
  358 
Table 3.  Summary of preoperative treatment 359 






Received treatment 42 (25.2%) 7 (2.4%) 51 (9.1%)* 
Types of treatment received    
Oral iron 7 (16.7%) 3 (42.9%) 12 (23.5%) 
Intravenous iron 27 (64.3%) 4 (57.1%) 31 (60.8%) 
Preoperative transfusion 8 (19.0%) 0 (0%) 8 (15.7%) 
    
* 2 patients received treatment without preoperative testings 360 
  361 
Table 4. Postoperative outcomes comparing different groups 362 





Mean hospital LOS (days) 9.93 7.88 p<0.001 
    
Number of patients transfused 
perioperatively 
42 (25.1%) 5 (1.7%) OR: 3.186, 
p=0.049 
 
Mean unit of blood transfused 2.43 1.40 p=0.36 
 363 
  364 
 365 
Figure 1.  Bar graph comparing screening laboratory parameters for two audits: Australian 366 
metropolitan teaching healthcare facility (AMTHF) and Australian ‘Blood Matters’ 2015 audits 367 
(DHHSV & BM 2016).  *Blood Matters audit data used with permission 368 
  369 
 370 
Figure 2.  Impact of anaemia status on hospital length of stay  371 
Key: 0.5=50% of the patients remain admitted.  372 
  373 
Box 1. Categories of audit questions  374 
Patient details • Patient record number 
• Age, Gender 
• Principal diagnosis 
• Comorbidities relevant to anaemia or increased bleeding or 
clotting risk e.g. inflammatory bowel disease, heart failure, 
ischaemic heart disease, chronic renal failure, haematological 
malignancy, haemoglobinopathy that requires regular 
transfusion 
Pre-surgical assessment for 
anaemia or bleeding risk 
Was the patient assessed?  If yes: 
• Time of assessment prior to surgery 
• Which blood tests results were available, specifically: vitamin 
B12, C-reactive protein (CRP), folate, full blood count (FBC), 
iron studies including ferritin and renal function 
• Screening results (anaemic vs non-anaemic) and anaemia 
classification  
• Whether the available blood test results indicated that treatment 
was required 
• Based on haematological values, whether treatment was required 
Was assessment in accordance with the PBM Guidelines? 
Surgical details • Surgical diagnosis related group (DRG) 
• Surgical team 
• Surgery conducted in a public or private hospital   
Hospital length of stay (LOS)  • Number of days 
Pre-operative treatment Was treatment provided? If yes specify: 
• Oral iron (dose, frequency of administration) 
• Intravenous iron (dose, rate, frequency of administration)  
• Transfusion 
Was treatment in accordance with PBM Guidelines? 
Contraindications to 
intravenous iron? 
• Known hypersensitivity, atopic allergies, fluid overload, acute 
renal dysfunction, hepatic impairment, infection, iron overload, 
sodium restriction, uncontrolled hyperparathyroidism 
Reassessment after treatment 
and before surgery (blood 
tests)? 
• Was the patient reassessed? If yes: 
• Was the patient optimised according to the PBM guidelines i.e. 
Hb >130g/L (male) or Hb > 120 g/L (female) 
Comparison of post-operative 
outcomes in anaemic vs non-
anaemic groups 
• Mean LOS 
• Number of patients transfused perioperatively 
• Mean unit(s) of blood transfused 
Postoperative treatment Was postoperative treatment provided?  If yes: 
• Transfusion and number of units 
• Was the transfusion clinically appropriate 
• Discharged on oral iron 
 375 
